My compounded semaglutide provider shut down. Where should I move my treatment?

Sorry that happened — that’s stressful. The safest move is to stop using any compounded vials you received from the closed provider and transfer your care to a licensed prescriber who will write an Rx for an FDA‑approved product or supervise a safe alternative. Quick recommendations and next steps:

Which products to consider (FDA‑approved semaglutide options)

• Wegovy (Novo Nordisk) — approved specifically for chronic weight management; consistent manufacturing, known dosing schedule.
• Ozempic (Novo Nordisk) — approved for type 2 diabetes; often used under physician supervision for weight loss as well.
• Rybelsus (Novo Nordisk) — oral semaglutide (daily) if you prefer a pill instead of injections.

Why use these instead of compounded semaglutide

• FDA‑approved products are manufactured under strict quality controls and have established dosing/labeling; compounded versions have had safety and contamination concerns and are less predictable.

Who to see for a new prescription

• Your primary care physician or endocrinologist — they can review your history, labs, and comorbidities and write an appropriate prescription.
• An obesity medicine specialist (find via the Obesity Medicine Association directory) if the primary reason is weight management.
• Reputable telehealth services that commonly prescribe and arrange delivery of FDA‑approved GLP‑1s: Ro (Roman), Hims & Hers, and One Medical — these can be convenient if you don’t have local specialty access (confirm they prescribe the product you want).

Where to fill

• Major retail and specialty pharmacies: CVS, Walgreens, Walmart, Costco, Kroger, and specialty pharmacies (e.g., CVS Specialty, Optum Specialty Pharmacy, Accredo) — call first to confirm stock and whether prior authorization is required.

Practical steps to transfer safely

1. Stop using the compounded supply and keep records/ receipts from the closed provider.
2. Get your medical records and medication history sent to your new prescriber.
3. Ask the new prescriber to evaluate your current dose and either transition you to an FDA‑approved semaglutide formulation or establish a safe alternative plan — do not self‑convert doses between compounded and commercial products.
4. Check insurance coverage and start prior‑authorization paperwork if needed; ask the prescriber or clinic to help.
5. Ask about manufacturer savings or patient assistance (Novo Nordisk offers patient support programs for Ozempic/Wegovy) if cost is a concern.
6. Arrange follow up and lab monitoring with your new provider.

If you want, tell me:

• whether your semaglutide was for diabetes or weight loss,
• your current dose/formulation, and
• whether you need help finding a local endocrinologist/obesity clinic or a telehealth option — I can suggest concrete clinics or help draft a message to send to a new provider.